[Spectral-analytical studies of the action of etifoxin on the human EEG].
Spectral analysis of EEG in healthy volunteers shows that Etifoxin, the hydrochloride of 6-chloro-4-methyl-4-phenyl-2-ethylamino-4H-3,1-benzoxazine (Hoe 36,801), in an oral dosage of 100 mg has a differential effect in function of the individual alpha organization. This differential effect appearing in the course of the quantitative evaluation can be interpreted, from a morphological point of view, as an expression of various partial phases and patterns of a process leading to reduced vigilance.
D000513:Alpha Rhythm; D000703:Analog-Digital Conversion; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D005583:Fourier Analysis; D006801:Humans; D010078:Oxazines / Q000008:administration & dosage / Q000494:pharmacology*; D010919:Placebos; D014149:Tranquilizing Agents
D010078:Oxazines; D010919:Placebos; D014149:Tranquilizing Agents
Spektralanalytische Untersuchungen zur Wirkung von Etifoxin auf das menschliche EEG